Ocular Therapeutix (OCUL) FCF Margin Growth (3y) (2017 - 2026)
Ocular Therapeutix (OCUL) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | -37,892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37,892.00 |
| Mar 31, 2026 | -44,959.00 |
| Dec 31, 2025 | -30,393.00 |
| Sep 30, 2025 | -27,797.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -29,365.00 |
| Dec 31, 2024 | -10,812.00 |
| Sep 30, 2024 | -13,113.00 |
| Jun 30, 2024 | 2,395.00 |
| Mar 31, 2024 | 548.00 |
| Dec 31, 2023 | -11,280.00 |
| Sep 30, 2023 | 22,393.00 |
| Jun 30, 2023 | 80,040.00 |
| Mar 31, 2023 | 54,885.00 |
| Dec 31, 2022 | 76,261.00 |
| Sep 30, 2022 | 241,104.00 |
| Jun 30, 2022 | 287,495.00 |
| Mar 31, 2022 | 383,404.00 |
| Dec 31, 2021 | 257,644.00 |
| Sep 30, 2021 | 209,912.00 |